AI and Decentralized Trials: A New Era in Drug Development | Healthcare IT Today
The following is a guest article by Matt Noble, Head of Patient Experience at Medidata The decentralized clinical trial (DCT) model has been around for almost fifteen years, with Pfizer pioneering the first fully decentralized study in 2011, and adoption accelerating significantly following the onset of the COVID-19 pandemic in 2020. The clinical research landscape